Profil de l'entreprise

Vous venez de lire:

Clementia Advances Phase 2 Clinical Trial of Palovarotene in Fibrodysplasia Ossificans Progressiva Based on Recommendations from Data Monitoring Committee (DMC)

Nouvelles fournies par

Clementia Pharmaceuticals, Inc.

Apr 02, 2015, 08:00 ET